NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Niki BioSolutions, Inc.
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$2.08+0.05 (+2.46%)
Close on Oct 19, 2026
- Market cap
- $16.66M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$13.42 (−86.58%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- $16.66M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.72
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$1.36M
- EPS, diluted
- -$0.19
- Book value per share
- $2.89
- Diluted shares
- 8M
Nine years at a glance
Fiscal years 2017 to 2025, USD
Revenue
–
Gross profit
–
Net income
-$1.36M
EPS, diluted
-$0.19
Free cash flow
–
Reported period